Home » Psychology news » Positive results for LATUDA (lurasidone HCI) in first placebo-controlled trial of patients with major depressive disorder with mixed features

Positive results for LATUDA (lurasidone HCI) in first placebo-controlled trial of patients with major depressive disorder with mixed features

May 21, 2015 by

Sunovion Pharmaceuticals Inc. has announced results from the first placebo-controlled study in adults with major depressive disorder (MDD) who presented with a limited number of associated manic...

Leave a Reply

Your email address will not be published. Required fields are marked *

*

You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>